1. Volume 3, Issue 5, Pages 415-424 (May 2016)
Scaling-up treatment of depression and anxiety: a global return on investment analysis 
Dr Dan Chisholm, PhD, Kim Sweeny, PhD, Prof Peter Sheehan, PhD, Prof Bruce Rasmussen, PhD, Prof Filip Smit, PhD, Prof Pim Cuijpers, PhD, Shekhar Saxena, MD 
The Lancet Psychiatry 
Volume 3, Issue 5, Pages (May 2016)
DOI: /S (16)
Copyright © 2016 Chisholm et al. Open Access article distributed under the terms of CC BY Terms and Conditions

2. Figure 1
Lost productivity attributable to depression and anxiety disorders at current treatment coverage, by country income level (US$ billion, 2013)
The Lancet Psychiatry 2016 3, DOI: ( /S (16) )
Copyright © 2016 Chisholm et al. Open Access article distributed under the terms of CC BY Terms and Conditions

3. Figure 2
Baseline, upper, and lower benefit to cost ratios for scaled-up treatment of depression and anxiety disorders, by country income group
The Lancet Psychiatry 2016 3, DOI: ( /S (16) )
Copyright © 2016 Chisholm et al. Open Access article distributed under the terms of CC BY Terms and Conditions